We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current MBIO market cap is 8.58M. The company's latest EPS is USD -1.0800 and P/E is -0.16.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -11.66M | -8.86M | -5.23M | -5.89M | -1.46M |
| Net Income | -10.06M | -8.62M | -5.19M | -8.2M | -1.41M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -45.89M | -56.81M | -66.72M | -76.16M | -50.73M |
| Net Income | -46.39M | -60.02M | -66.37M | -77.53M | -51.6M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 20.57M | 17.74M | 14.59M | 8.52M | 7.19M |
| Total Liabilities | 16.56M | 17.62M | 19.54M | 16.85M | 15.85M |
| Total Equity | 4.01M | 123k | -4.94M | -8.33M | -8.66M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 73.45M | 109.9M | 125.17M | 92.42M | 17.74M |
| Total Liabilities | 21.79M | 11.47M | 12.77M | 46.15M | 17.62M |
| Total Equity | 51.65M | 98.44M | 112.4M | 46.27M | 123k |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -42.22M | -49.48M | -5.32M | -7.66M | -9.41M |
| Investing | 5.92M | 5.89M | N/A | N/A | N/A |
| Financing | -30.04M | -26.08M | 49k | 5.32M | 6.33M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -33.58M | -37.32M | -53.67M | -65.07M | -49.48M |
| Investing | 13.91M | -4.41M | -5.37M | -2.95M | 5.89M |
| Financing | 65.12M | 78.12M | 70.85M | 34.06M | -26.08M |
| Market Cap | 8.58M |
| Price to Earnings Ratio | -0.16 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 1.3 |
| Price to Book Ratio | 66.04 |
| Dividend Yield | - |
| Shares Outstanding | 47.78M |
| Average Volume (1 week) | 827.4k |
| Average Volume (1 Month) | 640.15k |
| 52 Week Change | -86.89% |
| 52 Week High | 1.53 |
| 52 Week Low | 0.1281 |
| Spread (Intraday) | 0.01 (4.67%) |
| Company Name | Mustang Bio Inc |
| Address |
3500 south dupont highway dover, delaware 19901 |
| Website | https://www.mustangbio.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
